| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,350 | $30 | $147.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,890 | $30 | $122.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,700 | $10 | $62.7K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 1,550 | $40 | $54.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 370 | $90 | $33.5K |
| J0897 | Injection, denosumab, 1 mg | 1,080 | $20 | $20.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 140 | $100 | $13.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 110 | $50 | $5K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 140 | $20 | $3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 40 | $60 | $2.4K |